We are live on ! Find out more
LIA

LS Investment Advisors Portfolio holdings

AUM $738M
1-Year Est. Return 29.35%
This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+29.35%
3 Year Est. Return
+85.73%
5 Year Est. Return
+98.39%
10 Year Est. Return
+364.74%
AUM
$1.16B
AUM Growth
-$11.5M
Cap. Flow
-$9.61M
Cap. Flow %
-0.83%
Top 10 Hldgs %
18.08%
Holding
1,007
New
28
Increased
211
Reduced
349
Closed
12

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$10.2M
2
SEE
Sealed Air
SEE
+$9.05M
3
JPM icon
JPMorgan Chase
JPM
+$2.69M
4
NEOG icon
Neogen
NEOG
+$2.19M
5
CMCSA icon
Comcast
CMCSA
+$1.81M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$9.54M
2
AAPL icon
Apple
AAPL
+$2.86M
3
USB icon
US Bancorp
USB
+$2.5M
4
QCOM icon
Qualcomm
QCOM
+$2.08M
5
DHR icon
Danaher
DHR
+$1.62M

Sector Composition

Rank Sector Weight
1 Healthcare 15.83%
2 Financials 13.96%
3 Technology 13.67%
4 Industrials 9.18%
5 Consumer Discretionary 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADBE icon
251
Adobe
ADBE
$99.5B
$649K 0.06%
9,377
-21
-0.2% -$1.49K
ZBH icon
252
Zimmer Biomet
ZBH
$18.2B
$649K 0.06%
6,646
-54
-0.8% -$5.31K
BHI
253
DELISTED
Baker Hughes
BHI
$643K 0.06%
9,885
+1,709
+21% +$119K
CCI icon
254
Crown Castle
CCI
$33.3B
$638K 0.05%
7,919
-81
-1% -$6.26K
MU icon
255
Micron Technology
MU
$930B
$634K 0.05%
18,493
-222
-1% -$7.19K
HUM icon
256
Humana
HUM
$43.7B
$623K 0.05%
4,783
-79
-2% -$10K
TMO icon
257
Thermo Fisher Scientific
TMO
$213B
$622K 0.05%
5,112
+16
+0.3% +$1.95K
BND icon
258
Vanguard Total Bond Market
BND
$157B
$621K 0.05%
7,576
ISRG icon
259
Intuitive Surgical
ISRG
$127B
$620K 0.05%
12,087
+225
+2% +$11.2K
AON icon
260
Aon
AON
$76.5B
$606K 0.05%
6,908
-51
-0.7% -$4.45K
CERN
261
DELISTED
Cerner Corp
CERN
$604K 0.05%
10,131
-53
-0.5% -$2.98K
CAG icon
262
Conagra Brands
CAG
$6.94B
$598K 0.05%
23,273
-164
-0.7% -$4.04K
KSS icon
263
Kohl's
KSS
$2.17B
$598K 0.05%
9,804
-122
-1% -$6.9K
CMI icon
264
Cummins
CMI
$87.5B
$595K 0.05%
4,512
+834
+23% +$120K
APA icon
265
APA Corp
APA
$13.2B
$590K 0.05%
6,284
-62
-1% -$6.14K
ETN icon
266
Eaton
ETN
$161B
$588K 0.05%
9,278
-39
-0.4% -$2.77K
KDP icon
267
Keurig Dr Pepper
KDP
$42.3B
$584K 0.05%
9,087
-17,409
-66% -$1.06M
CRM icon
268
Salesforce
CRM
$151B
$580K 0.05%
10,076
-90
-0.9% -$5.07K
AMP icon
269
Ameriprise Financial
AMP
$48.3B
$576K 0.05%
4,670
-238
-5% -$29.2K
CME icon
270
CME Group
CME
$96.3B
$576K 0.05%
7,199
+48
+0.7% +$3.62K
VIAB
271
DELISTED
Viacom Inc. Class B
VIAB
$572K 0.05%
7,439
-104
-1% -$8.56K
ETR icon
272
Entergy
ETR
$50.2B
$569K 0.05%
14,720
+24
+0.2% +$909
ZTS icon
273
Zoetis
ZTS
$32.4B
$569K 0.05%
15,390
-408
-3% -$14K
TYC
274
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$567K 0.05%
12,145
-265
-2% -$12.3K
STJ
275
DELISTED
St Jude Medical
STJ
$563K 0.05%
9,359
-68
-0.7% -$4.44K

Similar funds

LS Investment Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, LS Investment Advisors held 1,007 positions worth $1.16B, down 0.98% from $1.17B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 4%. LS Investment Advisors opened 28 new positions and exited 12, leaving the 1,007-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

  • LS Investment Advisors's largest Q3 2014 buy was Neogen: 138,667 shares worth $2.05M.
  • LS Investment Advisors added most to Amgen in Q3 2014, an estimated $10.2M increase.
  • LS Investment Advisors's biggest Q3 2014 reduction was Praxair Inc, cutting an estimated $9.54M.
  • LS Investment Advisors fully exited Fidelity National Financial in Q3 2014, selling an estimated $257K.
  • LS Investment Advisors's ten largest holdings make up 18% of its $1.16B portfolio in Q3 2014.
  • LS Investment Advisors opened 28 new positions and closed 12 in Q3 2014.
  • LS Investment Advisors's portfolio value fell 0.98% quarter-over-quarter to $1.16B.

Based on LS Investment Advisors's 13F filing for Q3 2014, filed 28 Oct 2014.